Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OPEN vs GSK✓SelectedUSD · GSKOPEN vs GSK performance historyLatest closeAs of+4.42%11/17
Stock and ETF performance explorer

OPEN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-94.4%
GSK return
+43.9%
Excess return
-138.3%
Maximum drawdown
-97.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+4.4%-2.3%+6.7%+5.1%
7D-9.9%-3.0%-6.9%-9.1%
30D-44.2%+0.4%-44.6%-44.2%
3M-66.7%-1.2%-65.5%-66.5%
6M-73.1%+0.9%-74.0%-73.3%
YTD-79.8%+4.0%-83.8%-80.5%
1Y-84.9%+7.3%-92.2%-85.7%
3Y-51.8%+57.1%-108.9%-61.2%
5Y-94.4%+43.0%-137.3%-95.8%
All-94.4%+43.9%-138.3%-95.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling